Rising Scientific Powers India And China Compete For Bigger Shares Of Expanding Market In R&D Outsourcing
This article was originally published in PharmAsia News
Executive Summary
BEIJING - Global pharmaceutical players are likely to step up the transfer of research to specialist firms across China and India over the next decade, as the Asian giants continue to evolve into major scientific powers
You may also be interested in...
China Sprints Ahead Of India In Innovation Efforts, Says McKinsey Executive: Will The Gap Get Wider?
MUMBAI - China has far outpaced India on the innovation front even though the two Asian giants were at almost the same level barely 10 years ago, with China's rush ahead due to strong government initiatives on healthcare reforms and a constant flow of professionals with experience at Western global pharmaceutical companies returning to the motherland
Chinese CRO ShangPharma Moves Into Biologics To Follow Customer Trend
BEIJING - The leadership of Chinese contract research organization ShangPharma this week outlined plans to continue expanding the outfit's drug and biopharmaceutical research services through next year to attract more of the top international players
WuXi PharmaTech Set To Compete Globally Following OECD Certification Of New Drug Toxicology Lab In China
BEIJING - Armed with a new certification on good laboratory practice compliance from the Organization for Economic Cooperation and Development, WuXi PharmaTech's preclinical testing facility could be poised to battle the globe's giants in providing toxicology services for international players